161 related articles for article (PubMed ID: 38737660)
1. WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.
Goswami P; Patel T; Dave R; Singh G; Singh A; Kalonia T
J Med Life; 2024 Jan; 17(1):15-23. PubMed ID: 38737660
[TBL] [Abstract][Full Text] [Related]
2. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
3. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading.
Christofer Juhlin C; Mete O; Baloch ZW
Endocr Relat Cancer; 2023 Feb; 30(2):. PubMed ID: 36445235
[TBL] [Abstract][Full Text] [Related]
4. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.
Jung CK; Bychkov A; Kakudo K
Endocrinol Metab (Seoul); 2022 Oct; 37(5):703-718. PubMed ID: 36193717
[TBL] [Abstract][Full Text] [Related]
5. Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms.
J D
Cesk Patol; 2024; 60(1):59-63. PubMed ID: 38697828
[TBL] [Abstract][Full Text] [Related]
6. [Interpretation of the pathological diagnostic criteria and characteristics of high-grade thyroid follicular-derived carcinoma in the 5
Zhou J; Liu ZY
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1578-1583. PubMed ID: 38742344
[TBL] [Abstract][Full Text] [Related]
7. Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
Kakudo K; Bai Y; Liu Z; Li Y; Ito Y; Ozaki T
Endocr J; 2012; 59(1):1-12. PubMed ID: 21908930
[TBL] [Abstract][Full Text] [Related]
8. Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience.
Sakamoto A
Endocr Pathol; 2004; 15(4):307-11. PubMed ID: 15681854
[TBL] [Abstract][Full Text] [Related]
9. Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms.
Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
[TBL] [Abstract][Full Text] [Related]
10. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
[TBL] [Abstract][Full Text] [Related]
11. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract][Full Text] [Related]
12. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas.
Cracolici V; Cipriani NA
Endocr Pathol; 2023 Mar; 34(1):34-47. PubMed ID: 36692728
[TBL] [Abstract][Full Text] [Related]
13. Familial follicular cell tumors: classification and morphological characteristics.
Nosé V
Endocr Pathol; 2010 Dec; 21(4):219-26. PubMed ID: 20878367
[TBL] [Abstract][Full Text] [Related]
14. The 5
Basolo F; Macerola E; Poma AM; Torregrossa L
Endocrine; 2023 Jun; 80(3):470-476. PubMed ID: 36964880
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the WHO 2004 and WHO 2017 thyroid tumor classifications.
Patel N; Bavikar R; Lad YP; Singh M; Dharwadkar A; Viswanathan V
J Cancer Res Ther; 2024 Jan; 20(1):311-314. PubMed ID: 38554339
[TBL] [Abstract][Full Text] [Related]
16. [Interpretation of the fourth edition of WHO pathological classification of the thyroid tumors in 2017].
Zhang Y; Wu QL; Yun JP
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep; 53(9):718-720. PubMed ID: 30293272
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories.
Tallini G; Garcia-Rostan G; Herrero A; Zelterman D; Viale G; Bosari S; Carcangiu ML
Am J Surg Pathol; 1999 Jun; 23(6):678-85. PubMed ID: 10366150
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma.
González-Cámpora R; Galera-Ruiz D; Armas-Padrón JR; Otal-Salaverri C; Galera-Davidson H
Diagn Cytopathol; 1998 Jul; 19(1):4-8. PubMed ID: 9664176
[TBL] [Abstract][Full Text] [Related]
19. Post-radiotherapy cribriform-morular thyroid carcinoma.
Or Koca A; Güler Şimşek G
J Clin Lab Anal; 2023 Jan; 37(1):e24819. PubMed ID: 36535913
[TBL] [Abstract][Full Text] [Related]
20. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]